Developing gene therapy treatments for specific metabolic disorders
REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR ORGANIC ACIDEMIAS, PROPIONIC ACIDEMIA (PA) AND METHYLMALONIC ACIDEMIA TYPE B (MMAB)
This study is working on making it easier to get new gene therapy treatments approved for people with Propionic Acidemia and Methylmalonic Acidemia Type B, so that patients can have better options for managing their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project ID | NIH-11088092 on NIH RePORTER |
What this research studies
This research focuses on creating a regulatory framework to support the development of gene therapy treatments for organic acidemias, specifically Propionic Acidemia and Methylmalonic Acidemia Type B. The approach involves planning and preparing necessary documentation for meetings with the FDA, which is crucial for advancing these therapies towards clinical use. By ensuring that the regulatory pathways are clear and well-defined, the research aims to facilitate the approval process for these innovative treatments, ultimately benefiting patients with these genetic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Propionic Acidemia or Methylmalonic Acidemia Type B.
Not a fit: Patients with other metabolic disorders not related to Propionic Acidemia or Methylmalonic Acidemia Type B may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new gene therapy options that significantly improve the health and quality of life for patients with Propionic Acidemia and Methylmalonic Acidemia Type B.
How similar studies have performed: Similar research efforts in gene therapy for genetic disorders have shown promise, indicating that this approach could lead to successful treatment options.
Where this research is happening
Gaithersburg, United States
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.